Company:  BIOPHARMX CORP (BPMX)
Form Type:  424B5
Filing Date:  7/24/2017 
CIK:  0001504167 
Address:  1505 ADAMS DRIVE, SUITE D 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  650-889-5020 
Fiscal Year:  01/31 
Last Trade
Last Trade: 
$0.30  
Change: 
0.014 (4.90%)  
Trade Time: 
Sep 22  
Market Cap: 
$23.90M
Trade BPMX now with 

© 2017  
Description of Business
We are a specialty pharmaceutical company focused on utilizing our proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Our objective is to develop products that treat health or age­related conditions that: (1) are not presently being addressed or treated or (2) are currently treated with drug therapies or drug delivery approaches that are sub­optimal.
Register and access this filing in:     
  FORM 424B5
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS SUPPLEMENT
    The Offering
    RISK FACTORS
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    PRICE RANGE OF COMMON STOCK
    DIVIDEND POLICY
    DILUTION
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    RATIO OF EARNINGS TO FIXED CHARGES
    RISK FACTORS
    USE OF PROCEEDS
    SELLING STOCKHOLDERS
      BENEFICIAL OWNERS
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    DESCRIPTION OF DEBT SECURITIES
    DESCRIPTION OF WARRANTS
    DESCRIPTION OF UNITS